Skip to content

Clinical trials

Terminated Phase 1/2 Glioblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Status: Terminated Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20073
20094
20102
20112
20123
20133
20141
20165
20173
20191
20201
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
National Cancer Institute (NCI)3
Novartis Pharmaceuticals2
St. Joseph's Hospital and Medical Center, Phoenix2
AbbVie1
Alaunos Therapeutics1
Baylor College of Medicine1
Beth Israel Deaconess Medical Center1
Boneca Corporation1
Boston Scientific Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma36
Brain Neoplasms12
Glioma9
Astrocytoma8
Gliosarcoma8
Oligodendroglioma5
Neoplasms3
Recurrence3
Carcinoma, Non-Small-Cell Lung2
Diffuse Intrinsic Pontine Glioma2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.